Clinical Trials
2
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy
- Conditions
- Cancer
- Interventions
- Other: RNA sequencingOther: Transcriptome analysisDrug: palliative careDrug: target drug with the score above 0,1Drug: target drug with the score equal or below 0,1Drug: non-target drug
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- OmicsWay Corp.
- Target Recruit Count
- 200
- Registration Number
- NCT03724097
- Locations
- 🇺🇸
OmicsWay Corp., Walnut, California, United States
🇷🇺Kaluga Regional Clinical Oncology Center, Kaluga, Russian Federation
🇷🇺Oncological Clinical Dispensary No. 1 of the Moscow City Health Department, Moscow, Russian Federation
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
- Conditions
- HER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- OmicsWay Corp.
- Target Recruit Count
- 40
- Registration Number
- NCT03521245
- Locations
- 🇺🇸
OmicsWay Corp., Walnut, California, United States
🇷🇺Republican Oncological Dispensary of the Ministry of Healthcare of Karelia Republic, Petrozavodsk, Karelia Republic, Russian Federation
🇷🇺Vitamed LLC, Moscow, Russian Federation
News
No news found